AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
INTERIM RESULTS OF A PHASE-I TRIAL SUGGESTS THAT TOMUDEX (RALTITREXED) MAY ACT SYNERGISTICALLY WITH 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC)
Authors: SCHWARTZ GK BERTINO JL KEMENY N SALTZ L SUGARMAN A KELSEN DK TONG W LOWERY C SMITH M
Citation: Gk. Schwartz et al., INTERIM RESULTS OF A PHASE-I TRIAL SUGGESTS THAT TOMUDEX (RALTITREXED) MAY ACT SYNERGISTICALLY WITH 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 171-171
INTERIM RESULTS OF PHASE-I TRIAL SUGGESTS THAT TOMUDEX(TM) (RALTRITREXED) MAY ACT SYNERGISTICALLY WITH (5-FLOUROURACIL) 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
Authors: SCHWARTZ GK KEMENY N BERTINO J SALTZ L SUGARMAN A KELSEN DK TONG W LOWERY C
Citation: Gk. Schwartz et al., INTERIM RESULTS OF PHASE-I TRIAL SUGGESTS THAT TOMUDEX(TM) (RALTRITREXED) MAY ACT SYNERGISTICALLY WITH (5-FLOUROURACIL) 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 607-607
ADJUVANT THERAPY FOR COLORECTAL-CANCER (REPRINTED FROM CURR PROBL SURG, VOL 34, PG 601-676, 1997)
Authors: COHEN AM MINSKY BD NELSON H GUNDERSON LL MICHELASSI F SALTZ L KELSEN DP WILLETT CG ARENAS RB FAROUK R SCHILSKY RL
Citation: Am. Cohen et al., ADJUVANT THERAPY FOR COLORECTAL-CANCER (REPRINTED FROM CURR PROBL SURG, VOL 34, PG 601-676, 1997), Current problems in cancer, 22(1), 1998, pp. 5-77
A PILOT CLINICAL PHARMACOLOGICAL STUDY OF THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL ALONE AND IN COMBINATION WITH DOXORUBICIN/
Authors: SCHWARTZ GK WARD D SALTZ L CASPER ES SPIESS T MULLEN E WOODWORTH J VENUTI R ZERVOS P STORNIOLO AM KELSEN DP
Citation: Gk. Schwartz et al., A PILOT CLINICAL PHARMACOLOGICAL STUDY OF THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL ALONE AND IN COMBINATION WITH DOXORUBICIN/, Clinical cancer research, 3(4), 1997, pp. 537-543
PHASE-I TRIAL OF PN401, AN ORAL PRODRUG OF URIDINE, TO PREVENT TOXICITY FROM FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER
Authors: KELSEN DP MARTIN D ONEIL J SCHWARTZ G SALTZ L SUNG MT VONBORSTEL R BERTINO J
Citation: Dp. Kelsen et al., PHASE-I TRIAL OF PN401, AN ORAL PRODRUG OF URIDINE, TO PREVENT TOXICITY FROM FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1511-1517
PREOPERATIVE 5-FU, LOW-DOSE LEUCOVORIN, AND RADIATION-THERAPY FOR LOCALLY ADVANCED AND UNRESECTABLE RECTAL-CANCER
Authors: MINSKY BD COHEN AM ENKER WE SALTZ L GUILLEM JG PATY PB KELSEN DP KEMENY N ILSON D BASS J CONTI J
Citation: Bd. Minsky et al., PREOPERATIVE 5-FU, LOW-DOSE LEUCOVORIN, AND RADIATION-THERAPY FOR LOCALLY ADVANCED AND UNRESECTABLE RECTAL-CANCER, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 289-295
TOPOTECAN AND THE TREATMENT OF RECURRENT OVARIAN-CANCER - IS THERE A ROLE FOR GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: SALTZ L JANIK JE
Citation: L. Saltz et Je. Janik, TOPOTECAN AND THE TREATMENT OF RECURRENT OVARIAN-CANCER - IS THERE A ROLE FOR GRANULOCYTE-COLONY-STIMULATING FACTOR, Seminars in oncology, 24(1), 1997, pp. 26-30
PRELIMINARY-RESULTS OF PREOPERATIVE 5-FLUOROURACIL, LOW-DOSE LEUCOVORIN, AND CONCURRENT RADIATION-THERAPY FOR CLINICALLY RESECTABLE T3 RECTAL-CANCER
Authors: GRANN A MINSKY BD COHEN AM SALTZ L GUILLEM JG PATY PB KELSEN DP KEMENY N ILSON D BASSLOEB J
Citation: A. Grann et al., PRELIMINARY-RESULTS OF PREOPERATIVE 5-FLUOROURACIL, LOW-DOSE LEUCOVORIN, AND CONCURRENT RADIATION-THERAPY FOR CLINICALLY RESECTABLE T3 RECTAL-CANCER, Diseases of the colon & rectum, 40(5), 1997, pp. 515-522
ADJUVANT THERAPY FOR COLORECTAL-CANCER - IN BRIEF
Authors: COHEN AM MINSKY BD NELSON H GUNDERSON LL MICHELASSI F SALTZ L KELSEN DP WILLETT CG ARENAS RB FAROUK R SCHILSKY SL
Citation: Am. Cohen et al., ADJUVANT THERAPY FOR COLORECTAL-CANCER - IN BRIEF, Current problems in surgery, 34(8), 1997, pp. 605-676
CPT-11 (IRINOTECAN) AND 5-FLUOROURACIL - A PROMISING COMBINATION FOR THERAPY OF COLORECTAL-CANCER
Authors: SALTZ L SHIMADA Y KHAYAT D
Citation: L. Saltz et al., CPT-11 (IRINOTECAN) AND 5-FLUOROURACIL - A PROMISING COMBINATION FOR THERAPY OF COLORECTAL-CANCER, European journal of cancer, 32A, 1996, pp. 24-31
A PHASE-I TRIAL OF A MODIFIED, DOSE-INTENSIVE FAMTX REGIMEN (HIGH-DOSE 5-FLUOROURACIL PLUS DOXORUBICIN PLUS HIGH-DOSE METHOTREXATE PLUS LEUCOVORIN) WITH ORAL URIDINE RESCUE
Authors: SCHWARTZ GK CHRISTMAN K SALTZ L CASPER E QUAN V BERTINO J MARTIN DS COLOFIORE J
Citation: Gk. Schwartz et al., A PHASE-I TRIAL OF A MODIFIED, DOSE-INTENSIVE FAMTX REGIMEN (HIGH-DOSE 5-FLUOROURACIL PLUS DOXORUBICIN PLUS HIGH-DOSE METHOTREXATE PLUS LEUCOVORIN) WITH ORAL URIDINE RESCUE, Cancer, 78(9), 1996, pp. 1988-1995
A PROPOSED NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURALMESOTHELIOMA
Authors: AISNER J BOUTIN C BUTCHART EG CHAHINIAN P FABER LP HEELAN R MATTSON K PASS HI PATZ EF ROBINSON B RUSCH VW TAMMILEHTO L VOGELZANG NJ AISNER S ANTMAN KH BELANI CP BIGNON J BRODIN O FEINS R GINSBERG R HAMMAR S HERNDON J HILLARDEL G ILSON D KELLER S KELSEN D KRASNA M MAASILTA P MONNET I ROGGLI VL RUFFIE P SALMINEN U SALTZ L STRAUSS G VIALLAT JR VONBULTZINGSLOWEN F
Citation: J. Aisner et al., A PROPOSED NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURALMESOTHELIOMA, Chest, 108(4), 1995, pp. 1122-1128
A PHASE-II TRIAL OF INTERFERON-ALPHA 2A, 5-FLUOROURACIL, AND CISPLATIN IN PATIENTS WITH ADVANCED ESOPHAGEAL-CARCINOMA
Authors: ILSON DH SIROTT M SALTZ L HEELAN R HUANG Y KERESZTES R KELSEN DP
Citation: Dh. Ilson et al., A PHASE-II TRIAL OF INTERFERON-ALPHA 2A, 5-FLUOROURACIL, AND CISPLATIN IN PATIENTS WITH ADVANCED ESOPHAGEAL-CARCINOMA, Cancer, 75(9), 1995, pp. 2197-2202
A PHASE-II TRIAL OF PLEURECTOMY DECORTICATION FOLLOWED BY INTRAPLEURAL AND SYSTEMIC CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA/
Authors: RUSCH V SALTZ L VENKATRAMAN E GINSBERG R MCCORMACK P BURT M MARKMAN M KELSEN D
Citation: V. Rusch et al., A PHASE-II TRIAL OF PLEURECTOMY DECORTICATION FOLLOWED BY INTRAPLEURAL AND SYSTEMIC CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA/, Journal of clinical oncology, 12(6), 1994, pp. 1156-1163
A PHASE-I TRIAL OF IMMEDIATE POSTOPERATIVE INTRAPERITONEAL FLOXURIDINE AND LEUCOVORIN PLUS SYSTEMIC 5-FLUOROURACIL AND LEVAMISOLE AFTER RESECTION OF HIGH-RISK COLON-CANCER
Authors: KELSEN DP SALTZ L COHEN AM YAO TJ ENKER W TONG W TAO Y BERTINO JR
Citation: Dp. Kelsen et al., A PHASE-I TRIAL OF IMMEDIATE POSTOPERATIVE INTRAPERITONEAL FLOXURIDINE AND LEUCOVORIN PLUS SYSTEMIC 5-FLUOROURACIL AND LEVAMISOLE AFTER RESECTION OF HIGH-RISK COLON-CANCER, Cancer, 74(8), 1994, pp. 2224-2233
A PHASE-II TRIAL OF ALPHA-INTERFERON AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED CARCINOID AND ISLET-CELL TURNERS
Authors: SALTZ L KEMENY N SCHWARTZ G KELSEN D
Citation: L. Saltz et al., A PHASE-II TRIAL OF ALPHA-INTERFERON AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED CARCINOID AND ISLET-CELL TURNERS, Cancer, 74(3), 1994, pp. 958-961
A PHASE-I TRIAL OF INTRAHEPATIC VERAPAMIL AND DOXORUBICIN - REGIONAL THERAPY TO OVERCOME MULTIDRUG-RESISTANCE
Authors: SALTZ L MURPHY B KEMENY N BERTINO J TONG W KEEFE D YAO TJ TAO Y KELSEN D OBRIEN JP
Citation: L. Saltz et al., A PHASE-I TRIAL OF INTRAHEPATIC VERAPAMIL AND DOXORUBICIN - REGIONAL THERAPY TO OVERCOME MULTIDRUG-RESISTANCE, Cancer, 74(10), 1994, pp. 2757-2764
PREOPERATIVE 5-FLUOROURACIL, LOW-DOSE LEUCOVORIN, AND CONCURRENT RADIATION-THERAPY FOR RECTAL-CANCER
Authors: MINSKY B COHEN A ENKER W KELSEN D KEMENY N ILSON D GUILLEM J SALTZ L FRANKEL J CONTI J
Citation: B. Minsky et al., PREOPERATIVE 5-FLUOROURACIL, LOW-DOSE LEUCOVORIN, AND CONCURRENT RADIATION-THERAPY FOR RECTAL-CANCER, Cancer, 73(2), 1994, pp. 273-280
PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER
Authors: CHRISTMAN K KELSEN D SALTZ L TARASSOFF PG
Citation: K. Christman et al., PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, Cancer, 73(1), 1994, pp. 5-7
PHASE-I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (VOL 85, PG 1499, 1993)
Authors: SALTZ L SIROTT M YOUNG C
Citation: L. Saltz et al., PHASE-I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (VOL 85, PG 1499, 1993), Journal of the National Cancer Institute, 85(21), 1993, pp. 1777-1777
PHASE-I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: SALTZ L SIROTT M YOUNG C TONG W NIEDZWIECKI D JYUN YT TAO Y TROCHANOWSKI B WRIGHT P BARBOSA K TOOMASI F KELSEN D
Citation: L. Saltz et al., PHASE-I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of the National Cancer Institute, 85(18), 1993, pp. 1499-1507
GRANULOCYTE-COLONY-STIMULATING FACTOR - EFFECTIVE IN AMELIORATING FLUOROURACIL-BASED MYELOSUPPRESSION
Authors: CHRISTMAN K SALTZ L SCHWARTZ G FRIEDRICH C KELSEN D
Citation: K. Christman et al., GRANULOCYTE-COLONY-STIMULATING FACTOR - EFFECTIVE IN AMELIORATING FLUOROURACIL-BASED MYELOSUPPRESSION, Journal of the National Cancer Institute, 85(10), 1993, pp. 826-827
PREOPERATIVE COMBINED 5-FU, LOW-DOSE LEUCOVORIN, AND SEQUENTIAL RADIATION-THERAPY FOR UNRESECTABLE RECTAL-CANCER
Authors: MINSKY BD COHEN AM KEMENY N ENKER WE KELSEN DP SCHWARTZ G SALTZ L DOUGHERTY J FRANKEL J WISEBERG J
Citation: Bd. Minsky et al., PREOPERATIVE COMBINED 5-FU, LOW-DOSE LEUCOVORIN, AND SEQUENTIAL RADIATION-THERAPY FOR UNRESECTABLE RECTAL-CANCER, International journal of radiation oncology, biology, physics, 25(5), 1993, pp. 821-827
A PHASE-II TRIAL OF CARBOPLATIN IN PATIENTS WITH ADVANCED APUD TUMORS
Authors: SALTZ L LAUWERS G WISEBERG J KELSEN D
Citation: L. Saltz et al., A PHASE-II TRIAL OF CARBOPLATIN IN PATIENTS WITH ADVANCED APUD TUMORS, Cancer, 72(2), 1993, pp. 619-622
OCTREOTIDE AS AN ANTINEOPLASTIC AGENT IN THE TREATMENT OF FUNCTIONAL AND NONFUNCTIONAL NEUROENDOCRINE TUMORS
Authors: SALTZ L TROCHANOWSKI B BUCKLEY M HEFFERNAN B NIEDZWIECKI D TAO Y KELSEN D
Citation: L. Saltz et al., OCTREOTIDE AS AN ANTINEOPLASTIC AGENT IN THE TREATMENT OF FUNCTIONAL AND NONFUNCTIONAL NEUROENDOCRINE TUMORS, Cancer, 72(1), 1993, pp. 244-248
Risultati: 1-25 | 26-27